Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients

Abstract

Recent studies have demonstrated immunologic dysfunction in severely ill COVID-19 patients. We use single-cell RNA sequencing (scRNA-seq) to analyze the transcriptome of peripheral blood mononuclear cells (PBMC) from healthy (n=3) and COVID-19 patients with moderate disease (n = 5), acute respiratory distress syndrome (ARDS, n = 6), or recovering from ARDS (n = 6). Our data reveal transcriptomic profiles indicative of defective antigen presentation and interferon responsiveness in monocytes from ARDS patients, which contrasts with higher responsiveness to interferon signaling in lymphocytes. Furthermore, genes involved in cytotoxic activity are suppressed in both NK and CD8 lymphocytes, and B cell activation is deficient, which is consistent with delayed viral clearance in severely ill COVID-19 patients. Our study demonstrates that COVID-19 patients with ARDS have a state of immune imbalance in which dysregulation of both the innate and adaptive immune responses may be contributing to a more severe disease course.

Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review

“…Consistent with these findings, T cells isolated from the spleen of mice with DIO display altered mitochondrial phosphorylation and a preferential utilization of fatty acids as mitochondrial fuel. In COVID-19, T cells from patients with severe disease show an increased oxidative phosphorylation compared with mild or recovered groups, suggesting altered T cell metabolism in severe infection [ 98 ]. Furthermore, T cells from patients with progressed COVID-19 displayed an altered mitochondria morphology, increased mitochondrial mass and accumulation of ROS production.…”

SARS-CoV-2 infection: Understanding the immune system abnormalities to get an adequate diagnosis

“…Probably, the antiviral function of these CD8 + T cells is impaired by a defect in the priming process, or another possibility is that virusspecific CD8 + T cells have an excessive activation, which can affect the adequate function of the cells. On this sense, it has been reported that CD8+ T cells from severe COVID-19 patients display activation of IFN signaling that correlates with the disease severity, but contrary to the previous, Yao C et al identified that these CD8+ T cells (from severe COVID-19) have a gene expression profile related to a deficiency in cytotoxic function [55]. Severe COVID-19 patients have a reduced frequency of multi-functional CD4 + T cells (producers of at least two types of cytokines) and apparently, this functional damage predisposes to disease severity [53].…”

The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations

“…A multi-omics analysis of blood plasma collected from COVID-19 patients during the first week of infection following diagnosis revealed changes in the immune cell repertoire, increases in inflammatory markers and loss of metabolites and metabolic processes as the disease evolved from mild to moderate severity ( Su et al., 2020 ). A transcriptomics study characterized the single-cell RNA profile of peripheral mononuclear cells of COVID-19 patients, revealing defective antigen presentation in monocytes and high interferon responsiveness in lymphocytes, and suppression of genes involved in cytotoxic activity in both NK and CD8 lymphocytes, thus explaining the reduced viral clearance of severe COVID-19 patients ( Yao et al., 2020 ). Single-cell RNA-sequencing of host factors has also disclosed changes in cholesterol biosynthesis in the disease: increased cholesterol synthesis correlates with SARS-CoV-2 resistance ( Daniloski et al., 2020 ).…”